[Et<sub>3</sub>NH][HSO<sub>4</sub>]-mediated functionalization of hippuric acid: an unprecedented approach to 4-arylidene-2-phenyl-5(4H)-oxazolones
作者:Mehtab Parveen、Faheem Ahmad、Ali Mohammed Malla、Shaista Azaz、Manuela Ramos Silva、P. S. Pereira Silva
DOI:10.1039/c5ra09290f
日期:——
Facile, sustainable and economical synthesis of Erlenmeyer azlactones.
简便、可持续和经济的合成埃伦迈尔酰胺。
A Facile Preparation of 4-Arylidene-4,5-dihydrooxazol-5-ones using Zeolite as a Cyclodehydrating Agent
作者:Anima Boruah、Partha P. Baruah、Jagir S. Sandhu
DOI:10.1039/a802863j
日期:——
An efficient new method for the azlactonisation of acylamino acids using zeolite under mild conditions is described; the method is fairly general as well as providing high yields.
报道了一种在温和条件下使用分子筛对酰胺氨基酸进行高效新方法,该方法具有较高的产率。
Synthesis and Antibacterial Activity of Some Imidazole-5-(4H)one Derivatives
作者:Sampath Saravanan、Perumal Senthamil Selvan、Natesan Gopal、Jayanta Kumar Gupta、Biplap De
DOI:10.1002/ardp.200400944
日期:2005.10
significant antibacterialactivities. Furthermore, compounds containing –CH2CH2NH2, –CONH2 and –C6H4–N(CH3)2 groups as substitutents on the imidazolones were found to be potent antibacterial agents. Thus, among the twelve compounds, 1‐(2‐aminoethyl)‐2‐phen yl‐4‐(4‐(dimethylamino)benzylidene)imidazole‐5‐(4H)one (4d), 1‐carboxamido‐2‐phenyl‐4‐(4‐(dimethylamino)benzylidene)imidazole‐5‐(4H)one (4e) and 1‐(4‐(N
Insights on Cancer Cell Inhibition, Subcellular Activities, and Kinase Profile of Phenylacetamides Pending 1H-Imidazol-5-One Variants
作者:Maan T. Khayat、Abdelsattar M. Omar、Farid Ahmed、Mohammad I. Khan、Sara M. Ibrahim、Yosra A. Muhammad、Azizah M. Malebari、Thikryat Neamatallah、Moustafa E. El-Araby
DOI:10.3389/fphar.2021.794325
日期:——
bring interesting biological properties, especially in the field of kinase inhibitors. We sought to study tirbanibulin, a first-in-class dual Src kinase (non-ATP competitive)/tubulin inhibitor because there was not enough reporting about its structure–activity relationships (SARs). In particular, the present research is based on the replacement of the outer ring of the biphenyl system of 2-[(1,1′-
小分子药物的结构变化可能会带来有趣的生物学特性,尤其是在激酶抑制剂领域。我们试图研究 tirbanibulin,这是一种一流的双 Src 激酶(非 ATP 竞争性)/微管蛋白抑制剂,因为没有足够的关于其结构-活性关系 (SAR) 的报道。特别是,本研究基于2-[(1,1'-联苯)-4-基]-的联苯体系外环的置换。ñ-苄基乙酰胺,KX 化学型的已鉴定药效团,具有杂环。新合成的化合物在基于细胞的抗癌试验中显示出一系列活性,与清晰的 SAR 曲线一致。最有效的化合物,(Z)-ñ-benzyl-4-[4-(4-methoxybenzylidene)-2-methyl-5-oxo-4,5-dihydro-1H-imidazol-1-yl]phenylacetamide (KIM-161),具有细胞毒性 IC 50对 HCT116 结肠癌和 HL60 白血病细胞系的值分别为 294 和 362 nM。
Ramalingam; Padmanabha Reddy; Ramakanth Reddy, Indian Journal of Heterocyclic Chemistry, 2013, vol. 23, # 2, p. 165 - 170